Fortive Corporation (NYSE: FTV) is a Technology company in the Industrial - Machinery industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 35.59 | EPS (ttm) | 1.70 | Insider Own | 0.80% | Shs Outstand | 302.02M | Perf Week | -5.59% |
| Market Cap | 18.28B | Forward P/E | 18.65 | EPS next Y | 3.24 | Insider Trans | -2.26% | Shs Float | 277.73M | Perf Month | -4.86% |
| Enterprise Value | 21.41B | PEG | 4.20 | EPS next Q | 0.71 | Inst Own | - | Short Float | 4.81% | Perf Quarter | 0.72% |
| Income | 534.00M | P/S | 4.23 | EPS this Y | 77.17% | Inst Trans | - | Short Ratio | 4.31 | Perf Half Y | 12.68% |
| Sales | 4.32B | P/B | 3.01 | EPS next Y | 7.70% | ROA | 4.60% | Short Interest | 13.36M | Perf YTD | 9.60% |
| Book/sh | 20.09 | P/C | 48.87 | EPS next 5Y | 8.47% | ROE | 8.52% | 52W High | 64.56 -6.27% | Perf Year | 29.99% |
| Cash/sh | 1.24 | P/FCF | 18.73 | EPS past 3/5Y | -5.93% -16.55% | ROIC | 6.83% | 52W Low | 46.34 30.58% | Perf 3Y | 4.27% |
| Dividend Est. | 0.24 (0.40%) | EV/EBITDA | 19.97 | Sales past 3/5Y | -4.07% 2.11% | Gross Margin | 63.23% | Volatility | 3.74% 2.61% | Perf 5Y | 16.77% |
| Dividend TTM | 0.24 (0.40%) | EV/Sales | 4.96 | EPS Y/Y TTM | -27.97% | Oper. Margin | 18.23% | ATR (14) | 1.76 | Perf 10Y | 95.89% |
| Dividend Ex-Date | Jun 22, 2026 | Quick Ratio | 1.00 | Sales Y/Y TTM | -30.74% | Profit Margin | 12.38% | RSI (14) | 48.48 | Recom | 2.70 |
| Dividend Gr. 3/5Y | 4.47% 5.39% | Current Ratio | 1.24 | EPS Q/Q | 27.59% | SMA20 | -0.92% | Beta | 1.04 | Target Price | 65.33 |
| Payout | 10.55% | Debt/Eq | 0.50 | Sales Q/Q | -27.78% | SMA50 | -0.67% | Rel Volume | 0.90 | Prev Close | 59.46 |
| Employees | 10,000 | LT Debt/Eq | 0.36 | Earnings | Oct 28 | SMA200 | 6.23% | Avg Volume | 3.06M | Price | 60.51 |
| IPO Date | Jul 05, 2016 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 4.71% 2.57% | Net Debt/EBITDA | 2.92 | Volume | 2,739,625 | Change | 1.77% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-02-26 | Reiterated | Truist Securities | Hold | $61 → $67 |
| Jun-03-26 | Reiterated | Morgan Stanley | Equal Weight | $89 → $59 |
| May-11-26 | Upgrade | Argus Research | Hold → Buy | $85 → $68 |
| May-04-26 | Reiterated | Truist Securities | Hold | $56 → $61 |
| Apr-20-26 | Reiterated | Truist Securities | Hold | $58 → $56 |
| Feb-09-26 | Reiterated | Barclays | Equal Weight | $56 → $63 |
| Feb-05-26 | Reiterated | Seaport Global | $66 → $70 | |
| Feb-05-26 | Reiterated | Robert W. Baird | $58 → $65 | |
| Jan-16-26 | Downgrade | JP Morgan | Neutral → Underweight | |
| Jan-05-26 | Downgrade | Mizuho | Outperform → Underperform | $54 → $51 |
Fortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection. These products and services cater to diverse industries such as manufacturing, process industries, healthcare, utilities and power generation, communications, and electronics. Key brands within this segment include ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL. The company's Precision Technologies segment focuses on delivering critical measurement and control solutions. Its portfolio encompasses electrical testing and measurement instruments and related services, high-performance energetic material devices, and advanced sensor and control system solutions. These technologies are crucial for demanding sectors like power and energy management, medical equipment manufacturing, food and beverage production, aerospace and defense, off-highway vehicles, electronics, semiconductor fabrication, and various other industrial applications. This segment markets its offerings under brands such as ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX. Fortive's Advanced Healthcare Solutions division provides a comprehensive suite of hardware, software, and services specifically designed for the healthcare sector. This includes solutions for reprocessing and tracking medical instruments and devices, specialized biomedical testing tools, systems for radiation safety monitoring, and asset management services. Additionally, it offers subscription-based surgical inventory management platforms that optimize inventory and ensure regulatory adherence, alongside expert technical, analytical, and compliance services focused on determining radiation exposure. Brands in this segment include ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD. Established in 2015, Fortive Corporation maintains its corporate headquarters in Everett, Washington.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,316 | 5,143 | 6,232 | 6,065 | 5,826 | 5,255 | 4,634 | 4,564 | 6,453 | |
| Cost of Goods Sold Incl. D&A | 1,588 | 2,008 | 2,501 | 2,471 | 2,462 | 2,245 | 2,018 | 2,067 | 3,129 | |
| Gross Profit | 2,729 | 3,135 | 3,731 | 3,594 | 3,363 | 3,010 | 2,617 | 2,497 | 3,323 | |
| Selling, General and Administrative Excl. Other | 1,680 | 1,883 | 2,140 | 2,063 | 1,957 | 1,824 | 1,646 | 1,647 | 1,724 | |
| Research and Development | 263 | 342 | 414 | 398 | 402 | 355 | 321 | 320 | 414 | |
| Other Operating Expense | -1 | 1 | 0 | -1 | -1 | -1 | 0 | 1 | 0 | |
| Operating Income | 788 | 909 | 1,177 | 1,134 | 1,005 | 832 | 650 | 529 | 1,185 | |
| Interest Expense | 123 | 121 | 153 | 124 | 98 | 103 | 149 | 143 | 97 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 9 | -34 | -54 | -19 | -33 | -51 | 1,006 | -50 | -10 | |
| Net Income Before Taxes | 673 | 754 | 970 | 991 | 874 | 678 | 1,508 | 337 | 1,078 | |
| Income Taxes | 69 | 113 | 137 | 125 | 118 | 63 | 56 | 69 | 160 | |
| Consolidated Net Income | 534 | 579 | 833 | 866 | 755 | 608 | 1,613 | 739 | 2,914 | |
| Net Income From Continuing Operations | 602 | 641 | 833 | 866 | 755 | 614 | 1,452 | 268 | 918 | |
| Net Income | 534 | 579 | 833 | 866 | 755 | 608 | 1,613 | 739 | 2,914 | |
| EPS (Recurring) | 1.72 | 1.75 | 2.39 | 2.46 | 2.12 | 1.64 | 4.58 | 2.20 | 8.43 | |
| EPS (Basic, Before Extraordinaries) | 1.72 | 1.75 | 2.39 | 2.46 | 2.12 | 1.64 | 4.58 | 2.20 | 8.43 | |
| EPS (Diluted) | 1.70 | 1.74 | 2.36 | 2.43 | 2.09 | 1.63 | 4.30 | 2.17 | 8.31 | |
| EBITDA | 1,072 | 1,200 | 1,666 | 1,571 | 1,437 | 1,176 | 2,040 | 821 | 1,436 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 35.59 | 31.73 | 23.94 | 22.84 | 23.17 | 35.27 | 12.41 | 22.20 | 5.13 | |
| Price To Sales Ratio | 4.26 | 3.39 | 3.16 | 3.23 | 2.96 | 3.82 | 3.88 | 3.55 | 2.29 | |
| Gross Margin | 63.23 | 60.96 | 59.87 | 59.26 | 57.72 | 57.28 | 56.47 | 54.71 | 51.50 | |
| Operating Margin | 18.26 | 17.67 | 18.89 | 18.70 | 17.25 | 15.83 | 14.03 | 11.59 | 18.36 | |
| Net Margin | 12.37 | 11.26 | 13.37 | 14.28 | 12.96 | 11.57 | 34.81 | 16.19 | 45.16 | |
| Shares Outstanding | 304 | 316 | 349 | 353 | 356 | 349 | 337 | 336 | 346 | |
| Market Capitalization | 18,395 | 17,446 | 19,719 | 19,588 | 17,238 | 20,064 | 17,986 | 16,185 | 14,764 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Underwood Peter C | SVP - Chief Legal Officer | May 04 '26 | Option Exercise | 28.92 | 47,557 | 1,375,348 | 135,337 | May 06 |
| Underwood Peter C | SVP - Chief Legal Officer | May 04 '26 | Sale | 60.81 | 47,557 | 2,891,941 | 87,780 | May 06 |
| MITCHELL KATE | Director | Feb 18 '26 | Option Exercise | 29.58 | 7,131 | 210,935 | 38,906 | Feb 19 |
| MITCHELL KATE | Director | Feb 18 '26 | Sale | 58.34 | 7,131 | 416,023 | 31,775 | Feb 19 |
| Underwood Peter C | SVP - Chief Legal Officer | Nov 10 '25 | Option Exercise | 28.92 | 58,133 | 1,681,206 | 138,208 | Nov 12 |
| Underwood Peter C | SVP - Chief Legal Officer | Nov 10 '25 | Sale | 51.28 | 58,133 | 2,981,060 | 80,075 | Nov 12 |
| Walker Stacey A. | SVP - Chief People Officer | Oct 31 '25 | Sale | 50.35 | 2,192 | 110,367 | 59,488 | Nov 03 |
| Okerstrom Mark D | Chief Financial Officer | Aug 01 '25 | Buy | 47.03 | 21,300 | 1,001,739 | 94,622 | Aug 04 |
| LICO JAMES A | President and CEO | May 15 '25 | Sale | 72.40 | 175,000 | 12,670,000 | 428,585 | May 16 |
| Underwood Peter C | SVP - Chief Legal Officer | May 12 '25 | Sale | 73.88 | 14,327 | 1,058,479 | 51,750 | May 13 |
| Walker Stacey A. | SVP - Human Resources | Feb 28 '25 | Sale | 79.05 | 3,002 | 237,308 | 42,373 | Mar 04 |
| McLaughlin Charles E | SVP - Chief Financial Officer | Feb 28 '25 | Option Exercise | 35.84 | 16,467 | 590,177 | 108,211 | Mar 04 |
| McLaughlin Charles E | SVP - Chief Financial Officer | Feb 28 '25 | Sale | 78.86 | 32,085 | 2,530,223 | 76,126 | Mar 04 |
| Mulhall Christopher M. | VP - Chief Accounting Officer | Feb 26 '25 | Sale | 79.98 | 7,888 | 630,882 | 5,815 | Feb 28 |
| Walker Stacey A. | SVP - Human Resources | Feb 26 '25 | Sale | 80.52 | 5,688 | 457,998 | 47,141 | Feb 28 |